A detailed history of Yarbrough Capital, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Yarbrough Capital, LLC holds 2,541 shares of TMDX stock, worth $209,378. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,541
Previous 2,541 -0.0%
Holding current value
$209,378
Previous $382,000 4.19%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$72.62 - $150.62 $184,527 - $382,725
2,541 New
2,541 $382,000
Q4 2023

Jan 12, 2024

BUY
$36.74 - $81.08 $93,356 - $206,024
2,541 New
2,541 $200,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.62B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Yarbrough Capital, LLC Portfolio

Follow Yarbrough Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yarbrough Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yarbrough Capital, LLC with notifications on news.